Jun 30, 2026
In this first deep dive, Christopher Cogle explores the evolving landscape of acute myeloid leukaemia (AML). He discusses the challenge of translating research into real-world outcomes, emerging immunotherapies, precision diagnostics, and how innovations such as the Acute Leukemia Methylome Atlas may reshape AML management in the future.
Timestamps:
00:55 – Research Gaps
03:50 – Biologics
05:46 – AML Atlas
09:15 – Immunotherapy